Edward T H Yeh

Title: The Innovations of Edward T H Yeh

Introduction

Edward T H Yeh is a prominent inventor based in Houston, TX. He has made significant contributions to the field of biomedical research, particularly in understanding cardiotoxicity and cancer treatment. With a total of 7 patents, his work has had a profound impact on medical science.

Latest Patents

One of his latest patents focuses on "Topoisomerase 2b as a predictor of susceptibility to anthracycline-induced cardiotoxicity." This invention provides biomarkers for anthracycline cardiotoxicity and outlines methods for determining whether a subject will develop cardiotoxicity upon treatment with anthracyclines, such as doxorubicin, by measuring Top2b expression levels. Another significant patent involves "Methods and compositions relating to fortilin, an anti-apoptotic molecule." This invention discusses the interaction of Fortilin with p53, a tumor suppressor, and its potential applications in preventing apoptosis in hyperproliferative diseases, including cancer and atherosclerosis.

Career Highlights

Edward T H Yeh has worked with esteemed institutions such as the University of Texas System and the National Institutes of Health (NIH). His research has been pivotal in advancing our understanding of cardiotoxicity and cancer therapies.

Collaborations

Throughout his career, he has collaborated with notable colleagues, including Limin Gong and Vincenzo Pasceri. These partnerships have further enriched his research and innovations.

Conclusion

Edward T H Yeh's contributions to medical science through his patents and research collaborations highlight his role as a leading inventor in the field. His work continues to influence the development of treatments for serious health conditions.